Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Schramm

Showing results (151-160 of 228) with videos related to

Pageof 23
Sort By:
International Journal of Cancer|February 13, 2013
Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cellsKristian W Pajtler, Vera Rebmann, Monika Lindemann, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 11, 2009
Carotid artery stenting: do procedural complications relate to the side intervened upon?: results from the Carotid Artery Stent (CAS)-Registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)Ralf Zahn, Thomas Ischinger, Matthias Hochadel, et al.
Nucleic Acids Research|May 15, 2010
Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastomaJohannes H Schulte, Tobias Marschall, Marcel Martin, et al.
Oncogene|August 17, 2005
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profilingAlexander Schramm, Johannes H Schulte, Ludger Klein-Hitpass, et al.
Oncotarget|April 22, 2017
RITA displays anti-tumor activity in medulloblastomas independent of TP53 statusAline Gottlieb, Kristina Althoff, Laura Grunewald, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|April 6, 2024
Influence of analytical procedures on miRNA expression analyses in saliva samplesMario J J Scheurer, Alexander Wagner, Andreas Sakkas, et al.
Healthcare (Basel, Switzerland)|May 13, 2026
Patient Satisfaction and Supportive Care Pathways in a German Head and Neck Tumor Center: A Prospective Cross-Sectional StudyMario Scheurer, Philip Haller, Johannes Schulze, et al.
Journal for Immunotherapy of Cancer|May 21, 2021
Druggable epigenetic suppression of interferon-induced chemokine expression linked to <i>MYCN</i> amplification in neuroblastomaJohanna A Seier, Julia Reinhardt, Kritika Saraf, et al.
International Journal of Cancer|August 22, 2012
Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastomaAlexander Schramm, Johannes Köster, Tobias Marschall, et al.
Craniomaxillofacial Trauma & Reconstruction|January 18, 2021
The Global Impact of COVID-19 on Craniomaxillofacial SurgeonsJustin van der Tas, Thomas Dodson, Daniel Buchbinder, et al.
Pageof 23

Showing results (151-160 of 228) with videos related to

Sort By:
Pageof 23
International Journal of Cancer|February 13, 2013
Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cellsKristian W Pajtler, Vera Rebmann, Monika Lindemann, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 11, 2009
Carotid artery stenting: do procedural complications relate to the side intervened upon?: results from the Carotid Artery Stent (CAS)-Registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)Ralf Zahn, Thomas Ischinger, Matthias Hochadel, et al.
Nucleic Acids Research|May 15, 2010
Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastomaJohannes H Schulte, Tobias Marschall, Marcel Martin, et al.
Oncogene|August 17, 2005
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profilingAlexander Schramm, Johannes H Schulte, Ludger Klein-Hitpass, et al.
Oncotarget|April 22, 2017
RITA displays anti-tumor activity in medulloblastomas independent of TP53 statusAline Gottlieb, Kristina Althoff, Laura Grunewald, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|April 6, 2024
Influence of analytical procedures on miRNA expression analyses in saliva samplesMario J J Scheurer, Alexander Wagner, Andreas Sakkas, et al.
Healthcare (Basel, Switzerland)|May 13, 2026
Patient Satisfaction and Supportive Care Pathways in a German Head and Neck Tumor Center: A Prospective Cross-Sectional StudyMario Scheurer, Philip Haller, Johannes Schulze, et al.
Journal for Immunotherapy of Cancer|May 21, 2021
Druggable epigenetic suppression of interferon-induced chemokine expression linked to <i>MYCN</i> amplification in neuroblastomaJohanna A Seier, Julia Reinhardt, Kritika Saraf, et al.
International Journal of Cancer|August 22, 2012
Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastomaAlexander Schramm, Johannes Köster, Tobias Marschall, et al.
Craniomaxillofacial Trauma & Reconstruction|January 18, 2021
The Global Impact of COVID-19 on Craniomaxillofacial SurgeonsJustin van der Tas, Thomas Dodson, Daniel Buchbinder, et al.
Pageof 23